Arcus Biosciences (NYSE:RCUS) Issues Earnings Results, Misses Expectations By $0.03 EPS
Arcus Biosciences (NYSE:RCUS – Get Rating) issued its quarterly earnings data on Tuesday. The company reported ($1.09) EPS for the quarter, missing analysts’ consensus estimates of ($1.06) by ($0.03), Briefing.com reports. The business had revenue of $25.00 million during the quarter, compared to analyst estimates of $22.47 million. Arcus Biosciences had a negative net margin […]
Terryj Rosen Jennifer Jarrett Juan Carlos Jaen Northern Trust Corp Vanguard Group Inc Goldman Sachs Group Inc
Source: wkrb13.com